We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IBB market cap is 7.76B. The company's latest EPS is USD 5.6204 and P/E is 24.83.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 50.54M | 65.99M | 64.73M | 58.15M | 52.52M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -223.56M | 2.74B | -1.32B | -92.78M | 312.5M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.28B | 11.02B | 9.41B | 8.89B | 8.55B |
| Total Liabilities | 933.75M | 1.17B | 806.81M | 865.77M | 918.45M |
| Total Equity | 6.34B | 9.85B | 8.61B | 8.03B | 7.63B |
| Market Cap | 7.76B |
| Price to Earnings Ratio | 24.83 |
| Price to Sales Ratio | 147.71 |
| Price to Cash Ratio | 33.22k |
| Price to Book Ratio | 1.02 |
| Dividend Yield | - |
| Shares Outstanding | 55.6M |
| Average Volume (1 week) | 1.35M |
| Average Volume (1 Month) | 1.31M |
| 52 Week Change | 8.68% |
| 52 Week High | 141.16 |
| 52 Week Low | 111.83 |
| Spread (Intraday) | 2.05 (1.46%) |
| Company Name | iShares Biotechnology ETF |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.ishares.com |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
